Related Experiment Videos
Angle-closure glaucoma in a patient with systemic lupus erythematosus
1Department of Ophthalmology, University of Amsterdam, The Netherlands.
Documenta Ophthalmologica. Advances in Ophthalmology
|August 1, 1989
Summary
A patient with immune thrombocytopenic purpura (ITP) experienced angle-closure glaucoma due to posterior scleritis, responding to treatment. The case also involved central retinal vein occlusion and optic disc neovascularization, leading to vitreous hemorrhage despite interventions.
Area of Science:
- Ophthalmology
- Rheumatology
- Immunology
Background:
- A patient with a history of immune thrombocytopenic purpura (ITP) presented with secondary angle-closure glaucoma.
- The glaucoma was attributed to posterior scleritis, a condition often associated with systemic inflammatory diseases.
Observation:
- The patient's angle-closure glaucoma responded well to corticosteroid treatment and antiglaucoma therapy.
- Serological findings strongly suggested Systemic Lupus Erythematosus (SLE).
- Ocular findings included central retinal vein occlusion and later, neovascularization of the optic disc.
Findings:
- Despite panretinal photocoagulation for optic disc neovascularization, the condition did not improve.
- Subsequent cryocoagulation also failed to prevent a vitreous hemorrhage.
Implications:
- This case highlights the complex interplay between systemic autoimmune conditions like SLE and severe ocular manifestations.
- It underscores the challenges in managing sight-threatening complications such as neovascular glaucoma and vitreous hemorrhage in these patients.
- Early recognition and multidisciplinary management are crucial for optimizing outcomes in patients with co-existing ITP, posterior scleritis, and retinal vascular events.